Disorders of sexual differentiation in the adolescent

Annals of the New York Academy of Sciences

Volumn 1135, Issue , 2008, Pages 67-75

  Lee, Peter A ^a,b   Houk, Christopher P ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disorders of sex development (DSDs); Gonadal differentiation; Gonadal dysgensis; Molecular genetics; Primary amenorrhea

Indexed keywords

ALDOSTERONE; ANDROGEN; CHORIONIC GONADOTROPIN RECEPTOR; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADOTROPIN; GROWTH HORMONE; INHIBIN B; LUTEINIZING HORMONE RECEPTOR; MUELLERIAN INHIBITING FACTOR; PROGESTERONE; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ADOLESCENT; ALDOSTERONE BLOOD LEVEL; ANDROGEN INSENSITIVITY SYNDROME; BREAST APLASIA; CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; DELAYED PUBERTY; ENZYME DEFICIENCY; ESTROGEN BLOOD LEVEL; FEMINIZATION; FOLLITROPIN BLOOD LEVEL; GONADAL DYSGENESIS; GONADECTOMY; GONADOTROPIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GYNECOMASTIA; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; KARYOTYPE 46,XY; LEYDIG CELL; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; PATIENT ASSESSMENT; PRIMARY AMENORRHEA; PSYCHOLOGICAL ASPECT; ROKITANSKY SYNDROME; SEX DIFFERENTIATION DISORDER; SEX TRANSFORMATION; SEXUAL DEVELOPMENT; SEXUAL FUNCTION; SEXUAL ORIENTATION; SOCIAL PSYCHOLOGY; STEROID 17 ALPHA HYDROXYLASE DEFICIENCY; STEROID 21 MONOOXYGENASE DEFICIENCY; TESTOSTERONE 17 BETA DEHYDROGENASE DEFICIENCY; VAGINA APLASIA; VAGINA RECONSTRUCTION; VIRILIZATION;

EID: 45549096496     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1429.028     Document Type: Conference Paper

References (52)

1. Jost, A. 1953. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent. Prog. Horm. Res. 8 : 379 418.
2. Grumbach, M.M., I.A. Hughes & F.A. Conte. 2003. Disorders of Sex Differentiation. In Williams Textbook of Endocrinology, 10th ed. P.R. Larsen, H.M. Kronenberg, S. Melmed & K.S. Polonsky, Eds. : 842 1002. WB Saunders. Philadelphia, PA.
3. Lee, P.A., C.P. Houk, S.F. Ahmed, et al. 2006. Consensus statement on management of intersex disorders. Pediatrics 118 : e488 500.
4. Aittomaki, K., R. Herva U.H. Stenman, et al. 1995. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J. Clin. Endocrinol. Metab. 81 : 3722 3726.
5. Lim, H.N., S.H. Freestone, D. Romero, et al. 1998. Candidate genes in complete and partial XY sex reversal: mutation analysis of SRY, SRY-related genes, and FTZ-F1. Mol. Cell. Endocrinol. 140 : 51 58.
6. Kadandale, J.S., S.S. Wachtel, Y. Tunca, et al. 2000. Localization of SRY by primed in situ labeling in XX and XY sex reversal. Am. J. Med. Genet. 95 : 71 74.
7. Ergun-Longmire, B., G. Vinci, L. Alonso, et al. 2005. Clinical, hormonal and cytogenetic evaluation of 46,XX males and review of the literature. J. Pediatr. Endocrinol. Metab. 18 : 739 748.
8. Alvarez-Nava, F., S. Gonzalez, S. Soto. 1999. Mixed gonadal dysgenesis: a syndrome of broad clinical, cytogenetic and histopathologic spectrum. Genet. Couns. 10 : 233 243.
9. Telvi, L., A. Lebbar, O. Del Pino, et al. 1999. 45,X(46,XY mosaicism: report of 27 cases. Pediatrics 104 (2 Pt 1 304 308.
10. Mendez, J.P., A. Ulloa-Aguirre & S. Kofman-Alfaro, et al. 1993. Mixed gonadal dysgenesis: clinical, cytogenetic, endocrinological, and histopathological findings in 16 patients. Am. J. Med. Genet. 46 : 263 267.
11. Aleck, K.A., L. Argueso, J. Stone, et al. 1999. True hermaphroditism with partial duplication of chromosome 22 and without SRY. Am. J. Med. Genet. 85 : 2 4.
12. Jimenez, A.L., S. Kofman-Alfaro, J. Berumen, et al. 2000. Partially deleted SRY gene confined to testicular tissue in a 46,XX true hermaphrodite without SRY in leukocytic DNA. Am. J. Med. Genet. 93 (5 417 420.
13. Kuhnle, U., H.P. Schwarz, U. Lohrs, et al. 1993. Familial true hermaphroditism: paternal and maternal transmission of true hermaphroditism (46,XX) and XX maleness in the absence of Y-chromosomal sequences. Hum. Genet. 92 : 571 576.
14. Ramos, E.S., C.A. Moreira-Filho, Y.A. Vicente, et al. 1996. SRY-negative true hermaphrodites and an XX male in two generations of the same family. Hum. Genet. 97 : 596 598.
15. Sarafoglou, K. & H. Ostrer. 2000. Familial sex reversal: a review. J. Clin. Endocrinol. Metab. 85 : 483 493.
16. Kremer, H., R. Kraaij, S.P.A. Toledo, et al. 1995. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat. Genet. 9 : 160 164.
17. Laue, L.L., S.M. Wu, M. Kudo, et al. 1996. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol. Endocrinol. 10 : 987 997.
18. Wu, S.M., K.M. Hallermeier, L. Laue, et al. 1998. Inactivation of the luteinizing hormone (chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol. Endocrinol. 12 : 1651 1660.
19. Toldeo, S.P.A., H.G. Brunner, R. Kraaij, et al. 1996. An inactivation mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J. Clin. Endocrinol. Metab. 81 : 3850 3854.
20. Arnhold, I.J.P., A.C. Latronico, M.C. Batista, et al. 1997. Ovarian resistance to luteinizing hormone: a novel cause of amenorrhea and infertility. Fertil. Steril. 67 : 394 397.
21. Yanase, T., E.R. Simpson, M.R. Waterman. 2001. 17-alpha-hydroxylase, 17,20 lyase deficiency: from clinical investigation to molecular definition. Endocr. Rev. 12 : 91 108.
22. Auchus, R.J. 2001. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol. Metab. Clin. N. Am. 30 : 101 119.
23. Winter, J.S.D., R.M. Couch, J. Muller, et al. 1989. Combined 17-hydroxylase and 17,20 desmolase deficiencies: evidence for synthesis of a defective cytochrome p450c17. J. Clin. Endocrinol. Metab. 266 : 309 316.
24. Rosa, S., C. Duff, M. Meyer, et al. 2007. P450c17 deficiency: clinical and molecular characterization of six patients. J. Clin. Endocrinol. Metab. 92 : 1000 1007.
25. Andersson, S., W.M. Geissler, L. Wu, et al. 1996. Molecular genetics and pathophysiology of 17-beta-hydroxy-steroid dehydrogenase 3 deficiency. J. Clin. Endocr. Metab. 81 : 130 136.
26. Geissler, W.M., D.L. Davis, L. Wu, et al. 1994. Male pseudohermaphroditism caused by mutations of testicular 17-beta-hydroxysteroid dehydrogenase 3. Nat. Genet. 7 : 34 39.
27. Rösler, A., S. Silverstein, D. Abeliovich. 1996. A (R80Q) mutation in 17-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J. Clin. Endocrinol. Metab. 81 : 1827 1831.
28. Mendonça, B.B., I.J. Arnhold, W. Bloise, et al. 1999. 17-hydroxysteroid dehydrogenase 3 deficiency in women. J. Clin. Endocrinol. Metab. 84 : 802 804.
29. Andersson, S., D.W. Russell, J.D. Wilson. 1996. 17-hydroxysteroid dehydrogenase 3 deficiency. Trends Endocrinol. Metab. 7 : 121 126.
30. Mendonca, B.B., M. Inacio, I.J. Arnhold, et al. 2000. Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency: diagnosis, psychological evaluation, and management. Medicine 79 : 299 309.
31. Andersson, S., D.M. Berman, E.P. Jenkins, et al. 1991. Deletion of steroid 5-alpha-reductase gene in male pseudohermaphroditism. Nature 354 : 159 161.
32. Peterson, R.E., J. Imperato-McGinley, T. Gautier, et al. 1977. Male psuedohermaphroditism due to steroid 5 alpha-reductase deficiency. Am. J. Med. 62 : 170 191.
33. Imperato-McGinley, J.L., R.E. Peterson, T. Gautier, et al. 1979. Androgens and the evolution of male-gender identity among male psuedohermaphrodites with 5α-reductase deficiency. N. Eng. J. Med. 300 : 1233 1237.
34. Quigley, C.A., K.J. Friedman & A. Johnson, et al. 1992. Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. Clin. Endocr. Metab. 74 : 927 933.
35. Griffin JE, McPhaul MJ, Russell DW, Wilson JD. 2001. The androgen resistance syndromes: steroid 5α-reducatse deficiency, testicular feminization, and related disorders. In The Metabolic and Molecular Basis of Inherited Disease, 8th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, et al. Eds. : 4117 4146. McGraw-Hill. New York.
36. Griffin, J.E., C. Edwards, J.D. Madden, et al. 1976. Congenital absence of the vagina: the Mayer-Rokitansky-Kuster-Hauser syndrome. Ann. Intern Med. 85 : 224 236.
37. Seminara, S.B., J.C. Achermann, M. Genel, et al. 1999. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J. Clin. Endocrinol. Metab. 84 : 4501 4509.
38. Habiby, R.L., P. Boepple, L. Nachtigall, et al. 1996. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J. Clin. Invest. 98 : 1055 1062.
39. Merke, D.P., T. Tajima, J. Baron, et al. 1999. Brief report: hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N. Engl. J. Med. 340 : 1248 1252.
40. Latham, K., S. Fernandez, L. Iteld, et al. 2006. Pediatric breast deformity. J. Craniofac. Surg. 17 : 454 467.
41. Sadove, A.M. & J.A. van Aalst. 2005. Congenital and acquired pediatric breast anomalies: a review of 20 years' experience. Plast. Reconstr. Surg. 115 : 1039 1050.
42. Migeon, C.J., A.B. Wisniewski, T.R. Brown, et al. 2002. 46,XY intersex individuals: phenotypic and etiologic classification, knowledge of condition, and satisfaction with knowledge in adulthood. Pediatrics 110 : e32.
43. Benetti-Pinto, C.L., A. Bedone, L.A. Magna, et al. 2002. Factors associated with the reduction of bone density in patients with gonadal dysgenesis. Fertil. Steril. 77 : 571 575.
44. Krege, S., K.H. Walz, B.P. Hauffa, et al. 2000. Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty. BJU Int. 86 : 253 258.
45. Lean, W.L., A. Deshpande, J. Hutson, et al. 2005. Cosmetic and anatomic outcomes after feminizing surgery for ambiguous genitalia. J. Pediatr. Surg. 40 : 1856 1860.
46. Wisniewski, A.B. & C.J. Migeon. 2002. Gender role differentiation in adolescents affected by syndromes of abnormal sex differentiation. Adolesc. Med. 13 : 119 128.
47. Gupta, D.K., S. Shilpa, A.C. Amini, et al. 2006. Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects. Pediatr. Surg. Int. 22 : 905 909.
48. Maharaj, N.R., A. Dhai, R. Wiersma, et al. 2005. Intersex conditions in children and adolescents: surgical, ethical, and legal considerations. J. Pediatr. Adolesc. Gynecol. 18 : 399 402.
49. Creighton, S.M., C.L. Minto & S.J. Steele. 2001. Objective cosmetic and anatomical outcomes at adolescence of feminizing surgery for ambiguous genitalia done in childhood. Lancet 358 : 124 125.
50. Warne, G., S. Grover, J. Hutson, et al. 2005. A long-term outcome study of intersex conditions. J. Pediatr. Endocrinol. Metab. 18 : 555 567.
51. Martin, C.L., D.N. Ruble & J. Szkrybalo. 2002. Cognitive theories of early gender development. Psychol. Bull. 128 : 903 933.
52. Zucker, K.J. 2005. Measurement of psychosexual differentiation. Arch. Sex. Behav. 34 : 375 388.